latest news on glp 1 drugs The GLP-1 revolution: What UAB researchers are discovering about how these work New warning issued over compounded

Priorities to address this include: (a) patient-centered initiation of GLP-1s, including goals for weight reduction and health

Our preclinical findings highlight its potential therapeutic use for patients seeking improved glycemic control without the loss of appetite and emesis characteristic of current GLP-1 therapeutics

Often called the Triple G peptide, this investigational medication from Eli Lilly is showing results in clinical trials that we once thought were impossible without a scalpel

The USA shows growth at 5.2%, reflecting a mature healthcare market but strong demand for advanced treatments

September 4, 2024: Science Day held in the Ozempic lawsuit

Potential side effects of GLP-1 medications include nausea, vomiting, diarrhea and constipation, which may improve over time